SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Cannabis > OWC Pharmaceutical Research Corp. (OWCP)

<u>Here&rsquo;s our list of reasons as to why</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
3DYOGI Member Profile
 
Followed By 20
Posts 1,010
Boards Moderated 1
Alias Born 05/11/16
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2017 4:32:58 PM
Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry "NetworkNewsWire" - 3/16/2017 9:30:00 AM
Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth "NetworkNewsWire" - 3/15/2017 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2017 4:03:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/7/2017 6:06:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/2/2017 9:15:23 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/26/2017 5:15:05 PM
Cannabis Industry Sees Cautionary Optimism amid Trump Administration Uncertainty "NetworkNewsWire" - 1/25/2017 8:30:00 AM
Mounting Support for Marijuana Banking Has Widespread Implications "NetworkNewsWire" - 1/18/2017 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/17/2017 7:01:22 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2017 5:18:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/28/2016 1:21:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/22/2016 6:04:29 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/30/2016 6:06:35 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/28/2016 4:03:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/22/2016 2:11:34 PM
RT Minerals Corp. (TSX.V: RTM), High Grade Gold Norwalk Property, Drill Plan Ballard Lake Property "InvestorsHub NewsWire" - 11/22/2016 8:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/14/2016 3:07:44 PM
BONG!!!! The Cannabis Market is Smoking and We Have the Comprehensive Report "InvestorsHub NewsWire" - 11/14/2016 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2016 6:07:46 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/4/2016 4:11:34 PM
Global Sports Nutrition & Energy Drink Markets Push Billion Dollar Revenues Higher "InvestorsHub NewsWire" - 11/3/2016 9:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2016 11:19:35 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 10/24/2016 11:11:50 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 10/18/2016 3:10:50 PM
3DYOGI   Wednesday, 01/11/17 02:11:59 PM
Re: None
Post # of 74940 
Here’s our list of reasons as to why OWCP will be the cannabis stock of 2017:

Market Value: With a low $55 million Market Cap (as of January 11, 2017), they’re have tons of room for growth. We feel they’re so undervalued because they are still pre-revenue. But, that changes in Quarter 2 of 2017.

OTC QB, not Pink Sheets. Most people who are making an investment (not flipping) are usually uncomfortable with Pink Sheet stocks. To see the list of requirements and understand the line of thinking here, check out OTCmarkets.com.

Share Structure: The outstanding share count is 139,255,474 as of January 1, 2017. There’s a couple of cannabis sector stocks which far higher Market Values trading on the Pink Sheets with 2.3 BILLION outstanding shares

No Toxic Debt: Again, unlike many Pink Sheet companies — OWCP has no convertible notes whatsoever. Instead, they have non-interest bearing financing.

Distribution & Manufacturing Deals: Back in March 2016, they announced a manufacturing deal with Emilia Cosmetics, one of Israel’s largest private label cosmetics companies. In September 2016, OWCP got a $300,000 deal with MedMar for distribution in the USA. Then, in November 2016, OWCP announced a $300,000 deal with Michepro to promote, market, sell, and distribute products throughout Europe for a 25% cut.

Real Doctor(s): Dr. Yehuda Baruch, MD is a real doctor who was the head of the Israeli Medical Use of Cannabis Program from 2003 – 2012. Read more from the Medical Cannabis Conference website.
Products to Launch: You can see on ClinicalTrails.gov that there really is an ongoing study. On October 11th, 2016, they announced the Final Phase for Testing of their Psoriasis Cream. Then, on October 20th, 2016, they announced the completed development of a Medical Cannabis Sublingual Tablet — a smoke-free alternative.

Expert Advisors: OWCP has brilliant industry advisors like Jeffrey Friedland, who wrote the book “Marijuana: The World’s Most Misunderstood Plant“.

Provisional Patents
: OWCP has EIGHT provisional patents with the United States Patent and Regulatory Office (USPTO), all related to its line of activity related to cannabis-based medical products.

Acquisition
Offer: TEVA, a 115 year old pharmaceutical company with over $20 billion in revenue, made an offer to purchase OWCP’s patents! This leads me to believe there will be future offers as OWCP continues to advance their research and get closer to shipping products worldwide!

Comparison
: Simply compare GWPH to OWCP. That’s exactly what OWCP can become later this year. Want to be conservative? If OWCP grows to 1/3rd of GWPH’s Market Value, they’ll be trading around $7.18/share. The reason we feel this is realistic? GWPH has only one FDA approved product thus far. OWCP could easily have two (or more) out by the end of 2017.

AXIM .20-14.00+ last year
$OWCP will make a similar run. I believe OWCP has a more dynamic game changing company then AXIM
AXIM Market cap 710 Million
OWCP 55 Million Market today marching towards a billion dollar valuation


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist